Evidence map›Paper›PMID 41676535›Full record

ArticlebioRxiv : the preprint server for biology2026

Early-Enrichment Hit Discovery via Reversible-Work c(t) Estimation in Metadynamics (CTMD).

Venkata Sai Sreyas Adury, Pratyush Tiwary, Xinyu Gu, Mrinal Shekhar

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Venkata Sai Sreyas AduryBiophysics Program and Institute for Physical Science and Technology, University of Maryland, College Park 20742, USA.
Pratyush TiwaryDepartment of Chemistry and Biochemistry and Institute for Physical Science and Technology, University of Maryland, College Park 20742, USA.
Xinyu GuUniversity of Maryland Institute for Health Computing, Bethesda 20852, USA.
Mrinal ShekharCenter for Development of Therapeutics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Funding

Supplement to promote diversity: From atoms to mechanisms - Artificial Intelligence augmented molecular simulations for mechanistic ligand design.R35GM142719 · NIGMS · UNIV OF MARYLAND, COLLEGE PARK · PI TIWARY, PRATYUSH · 2021 to 2025
$2.0M
NIGMS NIH HHS R35 GM142719
6 · The paper itself

Abstract

Virtual screening for small-molecule binders is often limited by false positives from approximate scoring functions and rigid-receptor assumptions. These can be addressed downstream through accurate but expensive free energy calculations. At the same time, recent artificialintelligence-based co-folding methods have been proposed that claim to achieve accuracy of free energy methods at much lower cost, but these have not yet delivered consistent improvements in early enrichment and can be confounded by memorization. Here we address this gap by introducing c(t)-based metadynamics (CTMD), a physics-based, high-throughput hit-triaging protocol tailored for early enrichment. CTMD uses the nonequilibrium reversible-work estimator c(t) introduced by Tiwary and Parrinello (Journal of Physical Chemistry B, 2015 119 736), computed from a small number of short, independent well-tempered metadynamics trajectories, to rank binding stability without requiring converged binding free energies. Across diverse targets and chemotypes, CTMD provides robust early enrichment while remaining fast, transferable with minimal parameter tuning, and resistant to memorization-driven artifacts-underscoring both an immediately deployable physics-based alternative for screening. For these systems we show how co-folding, particularly Boltz-2, achieves enrichment directly proportional to similairty with training set, and more worrying, even in the presence of signficant modifications to active site. Given its simplicity of implementation, CTMD should thus be an "embarassingly" open-source, early enrichment method available for use by the broad pharma and academic community that sits right between approximate but fast docking or AI based co-folding methods, and more expensive but accurate free energy calculations, expected to lead to saving significant financial and human capital in drug discovery campaigns.

Identifiers

PMID41676535
PMCPMC12889651

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.